Qure's AMT-130 shows 80% Huntington's progress reduction, eyeing FDA approval. Click here to read why I rate QURE stock a Buy ...
In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long ...
Researchers identify a new player in human immunity that can go rogue and turn the immune system against the body’s own ...
Garda Rafael Liston told the court that Ms Cookes made admissions during questioning that she did not suffer from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results